Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2, indicating a minor patch. The 'Back to Top' text/link was removed as a secondary UI change.
    Difference
    0.3%
    Check dated 2025-09-14T21:45:39.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-07T18:15:30.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for Nivolumab and related topics, while removing several previous entries related to Relatlimab and other antineoplastic agents.
    Difference
    5%
    Check dated 2025-08-31T12:24:23.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:38:10.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:29:49.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    2%
    Check dated 2025-08-01T18:51:28.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.